Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Trelagliptin (25mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x1x4
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Trelanip 25 Tablet contains Trelagliptin (25mg), a once-weekly oral antidiabetic medication belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of incretin hormones in the body, which help to regulate blood sugar by increasing insulin release and decreasing glucagon levels, especially after meals. Trelagliptin has the advantage of once-weekly dosing, improving patient compliance and long-term glycemic control in individuals with type 2 diabetes mellitus. It does not typically cause weight gain or significant hypoglycemia when used alone.
Common side effects may include nasopharyngitis, headache, upper respiratory tract infections, and mild gastrointestinal disturbances. Although rare, hypoglycemia can occur, especially when used in combination with insulin or sulfonylureas. Allergic reactions, including skin rashes, have also been reported in some patients.
Trelanip 25 is indicated for the management of type 2 diabetes mellitus in adults to improve glycemic control as an adjunct to diet and exercise. It can be used as monotherapy or in combination with other antidiabetic agents, such as metformin or sulfonylureas.
This medication should be used under medical supervision, especially in patients with renal impairment or liver dysfunction. Routine monitoring of blood glucose levels is recommended. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.
Store in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Trelagliptin (100mg) Tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Trelagliptin 25mg Tablet has growing demand in the diabetology, endocrinology, general medicine, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on innovative anti-diabetic and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from increasing demand for Type 2 diabetes management under healthcare professional supervision. Trelagliptin 25mg is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps improve glycemic control by increasing endogenous incretin hormone activity, thereby enhancing glucose-dependent insulin secretion and reducing glucagon secretion Commonly prescribed as an adjunct to diet and exercise for the management of Type 2 Diabetes Mellitus in adults, as advised by healthcare professionals and approved prescribing information The 25mg strength may be selected for patients requiring dose adjustment, such as certain individuals with renal impairment, according to the prescribing information and clinical judgment of the treating physician Features a once-weekly oral dosing regimen, which may improve patient convenience and treatment adherence in appropriate patients Should be used under medical supervision with regular monitoring of blood glucose and HbA1c, along with lifestyle modifications including a balanced diet and regular exercise. It is not indicated for Type 1 diabetes mellitus or diabetic ketoacidosis Frequently utilized in diabetology clinics, endocrinology practices, general medicine departments, and chronic disease management programs Widely prescribed by diabetologists, endocrinologists, nephrologists, and general physicians for appropriate patients with Type 2 diabetes This strengthens a comprehensive anti-diabetic and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Trelagliptin 25mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from growing demand in the diabetes care market, increasing acceptance of innovative once-weekly oral therapies, reliable supply chain support, repeat prescriptions, and attractive margins in the chronic care segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality anti-diabetic products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.